November is Lung Cancer Awareness Month — an estimated 235,000 new cases of lung cancer and 125,000 deaths are expected to ...
The approval stipulates use in advanced, unresectable, or metastatic disease that progressed on prior systemic therapy.
The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...
A RECENT study examining the impact of airflow limitation (AL) on lung cancer (LC) screening outcomes suggests that the ...
The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a ...
1d
Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...
CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback